Vivani Medical Stock (NASDAQ:VANI)

Revenue Financials Chart

Previous Close

$1.18

52W Range

$1.00 - $7.80

50D Avg

$1.30

200D Avg

$1.46

Market Cap

$69.90M

Avg Vol (3M)

$115.81K

Beta

3.52

Div Yield

-

VANI Company Profile

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

36

IPO Date

Nov 19, 2014

Website

VANI Performance

VANI Financial Summary

	Dec 23	Dec 22	Dec 21
Revenue	-	-	-
Operating Income	$-26.96M	$-21.24M	$-13.32M
Net Income	$-25.65M	$-6.54M	$-12.13M
EBITDA	$-26.96M	$-27.74M	$-13.62M
Basic EPS	$-0.50	$-0.17	$-0.37
Diluted EPS	$-0.50	$-0.17	$-0.37

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts

Q4 19Mar 19, 20 | 5:00 PM

Q3 19Nov 15, 19 | 5:00 PM

Q2 19Aug 07, 19 | 5:00 PM

Peer Comparison

Ticker	Company
RLYB	Rallybio Corporation
TYRA	Tyra Biosciences, Inc.
TRDA	Entrada Therapeutics, Inc.
PMVP	PMV Pharmaceuticals, Inc.
ANTX	AN2 Therapeutics, Inc.
HCWB	HCW Biologics Inc.
PEPG	PepGen Inc.
ANEB	Anebulo Pharmaceuticals, Inc.
PHVS	Pharvaris N.V.